---
title: "Chemcel Biotech Ltd (533026) — Share Price, Financials & Analysis"
symbol: "533026"
company: "Chemcel Biotech Ltd"
canonical: "https://tapetide.com/stocks/533026"
isin: "INE213J01012"
bse_code: "533026"
generated_at: "2026-10-13T11:00:55.614Z"
---

# Chemcel Biotech Ltd (533026)

Canonical page: https://tapetide.com/stocks/533026

## Company

- **BSE Code:** 533026
- **ISIN:** INE213J01012
- **Stock Type:** EQUITY
- **Listed Since:** 2008-10-13
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** chemcelbiotechltd.com

## About

Chemcel Biotech Limited is an India-based company, which is a manufacturer of agro chemicals, such as insecticides, fungicides and plant growth promoters.

## Latest Price

## Key Insights

### Strengths

- Stock is trading at 0.06 times its book value

### Weaknesses

- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of -14.4% over past five years.
- Company might be capitalizing the interest cost
- Company has high debtors of 1,132 days.

## Growth Rates

| Metric | 1Y | 3Y | 5Y |
| --- | --- | --- | --- |
| net income growth | -3% | — | — |
| revenue growth | -19% | -33% | -14% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Jun 2014 | Sep 2014 | Dec 2014 | Mar 2015 |
| --- | --- | --- | --- | --- |
| Sales | 75.16 | 84.03 | 86.16 | 86.92 |
| Expenses | 70.87 | 73.74 | 74.97 | 79.84 |
| Operating Profit | 4.29 | 10.29 | 11.19 | 7.08 |
| OPM % | 5.71 | 12.25 | 12.99 | 8.15 |
| Other Income | -0.82 | 4.76 | 3.86 | 3.53 |
| Interest | 0.01 | 0 | 0.01 | 0 |
| Depreciation | 2.38 | 2.79 | 2.95 | 3.47 |
| Profit before tax | 1.08 | 12.26 | 12.09 | 7.14 |
| Tax % | 41.67 | -3.1 | 0.08 | -0.42 |
| Net Profit | 0.63 | 12.64 | 12.08 | 7.18 |
| EPS in Rs | 0.49 | 9.8 | 9.36 | 5.57 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2013 | Mar 2014 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 18.58 | 21.45 | 23.45 | 31.41 | 42.32 | 47.67 | 17.97 | 14.48 |
| Expenses | 17.15 | 19.18 | 20.55 | 28.36 | 39.39 | 45.2 | 19.18 | 14.81 |
| Operating Profit | 1.43 | 2.27 | 2.9 | 3.05 | 2.93 | 2.47 | -1.21 | -0.33 |
| OPM % | 7.7 | 10.58 | 12.37 | 9.71 | 6.92 | 5.18 | -6.73 | -2.28 |
| Other Income | 0.08 | 0.01 | 0 | 0 | 0 | 0 | 0.89 | 0 |
| Interest | 0.48 | 0.7 | 1.14 | 1.2 | 1.06 | 1.24 | 0 | 0 |
| Depreciation | 0.13 | 0.12 | 0.11 | 0.1 | 0.09 | 0.08 | 0.06 | 0.05 |
| Profit before tax | 0.9 | 1.46 | 1.65 | 1.75 | 1.78 | 1.15 | -0.38 | -0.38 |
| Tax % | 22.22 | 35.62 | 25.45 | 25.14 | 23.03 | 24.35 | 0 | 0 |
| Net Profit | 0.7 | 0.94 | 1.23 | 1.31 | 1.37 | 0.87 | -0.37 | -0.38 |
| EPS in Rs | — | — | — | 0.51 | 0.53 | 0.31 | -0.13 | -0.14 |
| Dividend Payout % | 95 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2013 | Mar 2014 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 6.65 | 10.52 | 10.52 | 25.92 | 25.92 | 27.92 | 27.92 | 27.92 |
| Reserves | 0.46 | 1.56 | 2.78 | 13.13 | 14.66 | 16.52 | 16.27 | 15.89 |
| Borrowings | 9.17 | 6.54 | 7.02 | 5.05 | 9.59 | 10.07 | 10.63 | 10.58 |
| Other Liabilities | 3.22 | 6.28 | 7.99 | 3.03 | 5.72 | 5.6 | 13 | 17.78 |
| Total Liabilities | 19.5 | 24.9 | 28.31 | 47.13 | 55.89 | 60.11 | 67.82 | 72.17 |
| Fixed Assets | 1.1 | 0.99 | 1.29 | 1.23 | 1.15 | 1.07 | 0.94 | 0.89 |
| CWIP | 5.8 | 0.13 | 0 | 7.37 | 7.37 | 7.37 | 7.37 | 7.37 |
| Investments | 0 | 0 | 0.03 | 0.03 | 0.03 | 0.03 | 0 | 0 |
| Other Assets | 12.6 | 23.78 | 26.99 | 38.5 | 47.34 | 51.64 | 59.51 | 63.91 |
| Total Assets | 19.5 | 24.9 | 28.31 | 47.13 | 55.89 | 60.11 | 67.82 | 72.17 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2013 | Mar 2014 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | -5.68 | -6.48 | — | -14.08 | -4.98 | -3.76 | 0.08 | -0.13 |
| Cash from Investing Activity | -5.79 | 5.65 | — | -8.67 | 0.25 | 0.25 | 0.03 | 0 |
| Cash from Financing Activity | 11.45 | 0.84 | — | 22.68 | 4.69 | 3.48 | -0.1 | 0.19 |
| Net Cash Flow | -0.02 | 0.01 | — | -0.07 | -0.04 | -0.03 | 0.01 | 0.06 |
| Free Cash Flow | -11.48 | -0.83 | — | -21.48 | -4.98 | -3.76 | 0.08 | -0.13 |
| CFO/OP | -397 | -285 | — | -447 | -170 | -141 | -7 | 39 |

### Ratios

| Item | Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2013 | Mar 2014 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 129.66 | 180.88 | 175.26 | 277.15 | 208.89 | 248.08 | 839.68 | 1132.05 |
| Inventory Days | — | — | — | 46.8 | 48.17 | 45.53 | 80.07 | 101.99 |
| Days Payable | — | — | — | 14.76 | 31.5 | 12.2 | 182.92 | 365.82 |
| Cash Conversion Cycle | 129.66 | 180.88 | 175.26 | 309.19 | 225.57 | 281.41 | 736.83 | 868.23 |
| Working Capital Days | 183.48 | 297.28 | 293.4 | 396.61 | 349.91 | 346.7 | 855.93 | 1063.49 |
| ROCE % | — | 12.38 | 14.33 | 9.16 | 6.03 | 4.57 | — | -0.7 |

## Filings & Documents

### Annual Reports

| Date | Document |
| --- | --- |
| Mar 2011 | [Annual Report 2011](https://www.bseindia.com/bseplus/AnnualReport/533026/5330260311.pdf) |
| Mar 2010 | [Annual Report 2010](https://www.bseindia.com/bseplus/AnnualReport/533026/5330260310.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Apr 2015 | Concall - Apr 2015 |
| Feb 2015 | Concall - Feb 2015 |
| Nov 2014 | Concall - Nov 2014 |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-10-13T11:00:55.614Z.